ERFSF
Eurofins Scientific SE
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Neutral
+19/100
Last price
83.29
▼ 3.94 (4.52%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
87.23
Day high
85.27
Day low
85.27
Volume
168
Market cap
$14.25B
P/E (TTM)
24.79
52W range
64.95 – 92.97
Trailing performance
Returnvs SPY
1W
-1.79%
-3.7%
1M
+3.09%
+1.6%
3M
+3.81%
+0.4%
6M
+12.21%
-2.8%
YTD
+13.63%
-0.3%
1Y
+16.16%
+0.4%
3Y
+49.53%
-32.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ERFSF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
63.37M
Total on file
Fundamentals
Market cap$14.25B
Enterprise value$18.34B
Revenue (TTM)$7.39B
Gross profit$1.71B
EBITDA$1.54B
Net income$469.90M
EPS (TTM)$3.36
Free cash flow$339.56M
Total cash$617.80M
Total debt$4.47B
Book value / share$24.06
Shares outstanding171.11M
Float110.07M
Short % of float—
Dividend yield1.01%
Beta (5Y)0.81
Valuation & profitability ratios
Trailing P/E24.79
Forward P/E—
PEG ratio0.97
Price / sales—
Price / book3.46
EV / revenue2.48
EV / EBITDA11.94
Gross margin23.13%
Operating margin16.17%
Profit margin7.17%
Return on equity11.33%
Return on assets5.99%
Debt / equity96.12
Current ratio1.13
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $7.30B | $6.95B | $6.51B | $6.71B | +5.0% |
| Operating revenue | $7.30B | $6.95B | $6.51B | $6.71B | +5.0% |
| Cost of revenue | $2.33B | $2.24B | $2.15B | $2.23B | +3.9% |
| Gross profit | $4.97B | $4.71B | $4.36B | $4.49B | +5.5% |
| Total operating expense | $4.15B | $3.99B | $3.82B | $3.70B | +4.2% |
| Operating income | $818.30M | $726.20M | $546.80M | $783.20M | +12.7% |
| Net interest income | -$146.50M | -$131.50M | -$117.80M | -$103.90M | -11.4% |
| Pre-tax income | $654.10M | $554.60M | $423.30M | $780.00M | +17.9% |
| Tax provision | $181.10M | $149.10M | $115.50M | $174.20M | +21.5% |
| Net income | $474.80M | $406.40M | $310.20M | $610.20M | +16.8% |
| Net income to common | $474.80M | $406.40M | $310.20M | $610.20M | +16.8% |
| Basic EPS | 2.64 | 2.13 | 1.61 | 3.17 | +23.9% |
| Diluted EPS | 2.55 | 2.09 | 1.57 | 3.07 | +22.0% |
| EBIT | $811.20M | $705.40M | $552.70M | $885.60M | +15.0% |
| EBITDA | $1.53B | $1.40B | $1.22B | $1.49B | +9.8% |
| Basic shares | 179.80M | 190.60M | 192.90M | 192.50M | -5.7% |
| Diluted shares | 186.50M | 194.50M | 197.90M | 199.00M | -4.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $791.20M | $613.90M | $1.22B | $486.60M | +28.9% |
| Cash & short-term investments | $791.20M | $613.90M | $1.22B | $486.60M | +28.9% |
| Accounts receivable | $1.10B | $1.09B | $1.07B | $1.05B | +0.2% |
| Inventory | $139.30M | $141.90M | $139.00M | $145.60M | -1.8% |
| Total current assets | $2.65B | $2.45B | $3.07B | $2.31B | +8.2% |
| Property, plant & equipment | $2.76B | $2.56B | $2.30B | $2.17B | +7.9% |
| Goodwill & intangibles | $5.35B | $5.63B | $5.35B | $5.44B | -5.0% |
| Total assets | $10.99B | $10.89B | $10.89B | $10.08B | +0.9% |
| Total current liabilities | $2.43B | $2.11B | $2.12B | $1.77B | +15.1% |
| Current debt | $588.90M | $328.60M | $458.30M | $85.10M | +79.2% |
| Long-term debt | $3.41B | $2.67B | $2.89B | $2.71B | +27.4% |
| Total debt | $4.43B | $3.61B | $3.93B | $3.33B | +22.8% |
| Total liabilities | $6.41B | $5.50B | $5.75B | $5.23B | +16.4% |
| Retained earnings | $3.02B | $2.69B | $2.39B | $2.33B | +12.3% |
| Shareholder equity | $4.54B | $5.34B | $5.08B | $4.78B | -14.9% |
| Working capital | $223.90M | $342.00M | $944.70M | $541.10M | -34.5% |
| Net tangible assets | -$803.80M | -$289.60M | -$269.90M | -$661.00M | -177.6% |
| Shares issued | 182.16M | 192.98M | 192.98M | 192.74M | -5.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $654.10M | $554.60M | $423.30M | $780.00M | +17.9% |
| Depreciation & amortisation | $629.50M | $596.90M | $565.00M | $504.40M | +5.5% |
| Stock-based compensation | $138.10M | $138.30M | $137.70M | $136.10M | -0.1% |
| Change in working capital | $52.00M | $51.40M | -$75.70M | $33.10M | +1.2% |
| Operating cash flow | $1.40B | $1.32B | $1.02B | $1.14B | +6.1% |
| Capital expenditure | -$834.80M | -$528.40M | -$550.10M | -$660.20M | -58.0% |
| Investing cash flow | -$1.08B | -$846.50M | -$681.10M | -$855.90M | -27.1% |
| Share buybacks | -$541.30M | -$271.90M | -$55.80M | -$15.80M | -99.1% |
| Dividends paid | -$107.70M | -$95.60M | -$191.90M | -$192.10M | -12.7% |
| Financing cash flow | -$101.60M | -$1.09B | $413.60M | -$311.30M | +90.7% |
| Free cash flow | $564.10M | $790.50M | $467.80M | $476.10M | -28.6% |
| End cash position | $787.80M | $613.20M | $1.22B | $483.20M | +28.5% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | YoY |
|---|---|---|---|
| Cash & equivalents | $791.20M | — | — |
| Cash & short-term investments | $791.20M | — | — |
| Accounts receivable | $1.10B | — | — |
| Inventory | $139.30M | $145.90M | -4.5% |
| Total current assets | $2.65B | $2.62B | +1.3% |
| Property, plant & equipment | $2.76B | $2.44B | +13.4% |
| Goodwill & intangibles | $5.35B | $5.31B | +0.8% |
| Total assets | $10.99B | $10.59B | +3.8% |
| Total current liabilities | $2.43B | — | — |
| Current debt | $588.90M | $384.10M | +53.3% |
| Long-term debt | $3.41B | $3.17B | +7.4% |
| Total debt | $4.43B | $4.11B | +7.7% |
| Total liabilities | $6.41B | $5.91B | +8.4% |
| Retained earnings | $3.02B | — | — |
| Shareholder equity | $4.54B | $4.64B | -2.0% |
| Working capital | $223.90M | $533.40M | -58.0% |
| Net tangible assets | -$803.80M | -$671.80M | -19.6% |
| Shares issued | 182.16M | — | — |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $7.53B | +3.3% |
| Next year | — | — | $7.94B | +5.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders36.50%
Held by institutions33.80%
Institutions holding351
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
86.69
-3.92% from price
SMA 20
86.63
-3.86% from price
SMA 50
84.34
-1.25% from price
SMA 100
79.75
+4.44% from price
SMA 200
78.20
+6.51% from price
EMA 12
86.23
-3.41% from price
EMA 26
85.85
-2.99% from price
EMA 50
84.19
-1.07% from price
RSI (14)
45.3
Neutral
MACD (12,26,9)
0.38
Hist -0.55
ATR (14)
4.23
5.08% of price
Realised vol 30D
42.9%
Annualised
Bollinger upper
91.85
20, 2σ
Bollinger lower
81.42
20, 2σ
50 / 200 cross
Golden
84.34 vs 78.20
Trend bias
Above 200
+6.51%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.01
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
42.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-22.7%
Peak to trough
Max drawdown 5Y
-64.6%
Peak to trough
ATR 14
4.23
5.08% of price
Beta (reported)
0.81
5Y monthly, from filing
Dividends & splits
Forward rate$0.84 / yr
Forward yield1.01%
5-year avg yield1.12%
Payout ratio25.00%
Ex-dividend dateApr 28, 2026
Next pay date—
Last split10:1
Split dateNov 19, 2020
Headlines
Eurofins Scientific: Director/PDMR Shareholding
Business Wire · 19h ago
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 September 2026
Business Wire · 2d ago
Eurofins Scientific: Director/PDMR Shareholding
Business Wire · 3d ago
Eurofins Scientific SE: Weekly Report on Share Repurchases from 28th September to 2nd October 2026
Business Wire · 3d ago
Eurofins Scientific SE: Director/PDMR Shareholding
Business Wire · 6d ago
Eurofins Completes the Divestment of Its Electrical & Electronic Testing Business to UL Solutions
Business Wire · 6d ago
Eurofins Completes the Acquisition of Element Materials Technology’s Life Sciences Testing Services Business in North America
Business Wire · 6d ago
UL Solutions Completes Acquisition of Eurofins' Electrical, Electronics Business
MT Newswires · 7d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.